Paper38947210
Bioreversible Anionic Cloaking Enables Intracellular Protein Delivery with Ionizable Lipid Nanoparticles.
Alamgir A and 3 others. ACS Cent Sci, 2024. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Bioreversible Anionic Cloaking Enables Intracellular Protein Delivery with Ionizable Lipid Nanoparticles. Papers, record 38947210. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38947210
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bioreversible Anionic Cloaking Enables Intracellular Protein Delivery with Ionizable Lipid Nanoparticles.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| S10 OD032251 | NIH HHS | United States | S10OD032251 | PubMed |
Source NIH RePORTER
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26702034 | Gene therapy: progress and predictions. | Proc Biol Sci | 2015 | https://conductscience.org/library/papers/26702034 | PubMed |
| 2 | 36596858 | 2022 FDA approvals. | Nat Rev Drug Discov | 2023 | https://conductscience.org/library/papers/36596858 | PubMed |
| 3 | 21572409 | A roadmap to generate renewable protein binders to the human proteome. | Nat Methods | 2011 | https://conductscience.org/library/papers/21572409 | PubMed |
| 4 | 35346768 | The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs. | J Control Release | 2022 | https://conductscience.org/library/papers/35346768 | PubMed |
| 5 | 23664777 | ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. | Trends Biotechnol | 2013 | https://conductscience.org/library/papers/23664777 | PubMed |
| 6 | 32251383 | Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. | Nat Nanotechnol | 2020 | https://conductscience.org/library/papers/32251383 | PubMed |
| 7 | 25357182 | Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. | Nat Biotechnol | 2015 | https://conductscience.org/library/papers/25357182 | PubMed |
| 8 | 21154794 | Drug delivery using nanoparticle-stabilized nanocapsules. | Angew Chem Int Ed Engl | 2011 | https://conductscience.org/library/papers/21154794 | PubMed |
| 9 | 34421476 | Nanogel-facilitated Protein Intracellular Specific Degradation through Trim-Away. | Adv Funct Mater | 2021 | https://conductscience.org/library/papers/34421476 | PubMed |
| 10 | 11818562 | Probing protein conformational changes in living cells by using designer binding proteins: application to the estrogen receptor. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/11818562 | PubMed |
| 11 | 31206027 | A boronic acid-rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing. | Sci Adv | 2019 | https://conductscience.org/library/papers/31206027 | PubMed |
| 12 | 9065401 | Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. | Science | 1997 | https://conductscience.org/library/papers/9065401 | PubMed |
| 13 | 33034131 | Synergistic Interplay of Covalent and Non-Covalent Interactions in Reactive Polymer Nanoassembly Facilitates Intracellular Delivery of Antibodies. | Angew Chem Int Ed Engl | 2021 | https://conductscience.org/library/papers/33034131 | PubMed |
| 14 | 37115558 | Lipid Nanoparticle Delivery of Small Proteins for Potent In Vivo RAS Inhibition. | ACS Appl Mater Interfaces | 2023 | https://conductscience.org/library/papers/37115558 | PubMed |
| 15 | 36920197 | Modular Diazo Compound for the Bioreversible Late-Stage Modification of Proteins. | J Am Chem Soc | 2023 | https://conductscience.org/library/papers/36920197 | PubMed |
| 16 | 33199717 | The once and future gene therapy. | Nat Commun | 2020 | https://conductscience.org/library/papers/33199717 | PubMed |
| 17 | 26192320 | Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown. | Nat Biotechnol | 2015 | https://conductscience.org/library/papers/26192320 | PubMed |
| 18 | 29808576 | Bioinspired Diselenide-Bridged Mesoporous Silica Nanoparticles for Dual-Responsive Protein Delivery. | Adv Mater | 2018 | https://conductscience.org/library/papers/29808576 | PubMed |
| 19 | 27474402 | Virus-like particles as drug delivery vectors. | Acta Biochim Pol | 2016 | https://conductscience.org/library/papers/27474402 | PubMed |
| 20 | 27274052 | PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27274052 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42677397 | Protein Modifications for Cellular Protein Delivery. | Chem Rev | 2026 | https://conductscience.org/library/papers/42677397 | PubMed |
| 42293396 | Polyelectrolyte nanoparticles enable intracellular delivery of STING protein fragments for ovarian cancer immunotherapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42293396 | PubMed |
| 41942053 | Therapeutic peptides and proteins: Status and developments in drug delivery. | J Control Release | 2026 | https://conductscience.org/library/papers/41942053 | PubMed |
| 41146908 | Anionic lipids direct efficient microfluidic encapsulation of stable and functionally active proteins in lipid nanoparticles. | Commun Mater | 2025 | https://conductscience.org/library/papers/41146908 | PubMed |
| 40704024 | Combined cancer immunotherapy with lipid nanoparticle delivery of oligo-based cGAS-agonistic adjuvant and peptide or mRNA vaccines. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/40704024 | PubMed |
| 40619768 | Carriers Multimerize STING Protein Fragments to Activate Type I Interferon Signaling in STING-Deficient Cancer Cells. | Mol Pharm | 2025 | https://conductscience.org/library/papers/40619768 | PubMed |
| 40430958 | Novel Delivery of Cyclic-Diguanylate Monophosphate Utilizing Amyloid Depots. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40430958 | PubMed |
| 40324952 | Nanoparticle-Mediated Targeted Protein Degradation: An Emerging Therapeutics Technology. | Angew Chem Int Ed Engl | 2025 | https://conductscience.org/library/papers/40324952 | PubMed |
| 40056044 | Optimization of Lipid Nanoparticles with Robust Efficiency for the Delivery of Protein Therapeutics to Augment Cancer Immunotherapy. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40056044 | PubMed |
| 39206956 | Chemoselective Reagents for the Traceless Bioreversible Modification of Native Proteins. | Bioconjug Chem | 2024 | https://conductscience.org/library/papers/39206956 | PubMed |
| 39201377 | Drug Delivery Strategies for Age-Related Diseases. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201377 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| RNASE1 | 6035 | PubTator's text mining | https://conductscience.org/library/genes/6035 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38947210
GET https://conductscience.org/api/papers/v1/38947210/references?page=2